Orthofix Medical Inc. (OFIX) — Financial statements
Income statement, balance sheet, and cash flow for Orthofix Medical Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 822↑2.9% | 799↑7.1% | 747↑62.1% | 461↓0.8% | 464 | |
| Cost of Revenue | 271↑6.7% | 254↓2.6% | 260↑110.7% | 124↑7.5% | 115 | |
| Gross Profit | 552↑1.1% | 546↑12.3% | 486↑44.2% | 337↓3.5% | 350 | |
| Operating Expenses | ||||||
| R&D Expenses | 57↓22.4% | 74↓8.2% | 80↑63.5% | 49↓1.1% | 50 | |
| General & Administrative Expenses | 0.00↓100.0% | 533↑268.1% | 145↑80.9% | 80↑15.3% | 69 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 386↑68.6% | 229↑3.4% | 221 | |
| SG&A Expenses | 456↓14.3% | 533↑0.4% | 530↑71.8% | 309↑6.2% | 291 | |
| Other Expenses | 107↑338.4% | 24↑64.9% | 15↑299.3% | -7↓142.1% | 18 | |
| Operating Expenses | 620↓1.6% | 631↑0.8% | 625↑78.5% | 350↓2.1% | 358 | |
| Total Costs & Expenses | 891↑0.8% | 884↓0.2% | 886↑86.9% | 474↑0.3% | 473 | |
| Operating Results | ||||||
| Operating Income | -68↑19.1% | -85↑39.2% | -139↓948.5% | -13↓59.6% | -8 | |
| Depreciation & Amortization | 51↓15.1% | 60↓0.8% | 61↑88.8% | 32↓3.1% | 33 | |
| EBITDA | -22↑34.6% | -34↑57.0% | -79↓607.7% | 16↓27.0% | 21 | |
| EBIT | -73↑22.2% | -94↑32.7% | -140↓753.0% | -16↓40.8% | -12 | |
| Interest & Other Income | ||||||
| Net Interest Income | -17↑41.0% | -30↓243.3% | -9↓570.1% | -1↑29.9% | -2 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 17↓41.0% | 30↑243.3% | 9↑570.1% | 1↓29.9% | 2 | |
| Non-Operating Income | 5↓49.6% | 10↑926.1% | 0.94↓70.2% | 3↓5.8% | 3 | |
| Other Income / Expenses | -22↑43.1% | -39↓310.2% | -10↓115.6% | -4↑14.3% | -5 | |
| Income Before Tax | -91↑26.7% | -124↑16.7% | -149↓739.7% | -18↓31.2% | -13 | |
| Income Tax Expense | 1↓34.9% | 2↓21.9% | 3↑32.9% | 2↓91.8% | 25 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -92↑26.8% | -126↑16.8% | -151↓666.6% | -20↑48.5% | -38 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -92↑26.8% | -126↑16.8% | -151↓666.6% | -20↑48.5% | -38 | |
| Bottom-Line Net Income | -92↑26.8% | -126↑16.8% | -151↓666.6% | -20↑48.5% | -38 | |
| EPS (Basic) | -2.28↑30.9% | -3.30↑19.9% | -4.12↓320.4% | -0.98↑49.7% | -1.95 | |
| EPS (Diluted) | -2.28↑30.9% | -3.30↑19.9% | -4.12↓320.4% | -0.98↑49.7% | -1.95 | |
| Weighted Average Shares | 40↑4.6% | 38↑3.8% | 37↑82.7% | 20↑2.1% | 20 | |
| Weighted Average Diluted Shares | 40↑4.6% | 38↑3.8% | 37↑82.7% | 20↑2.1% | 20 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.